Get started
Author

Faustine d’Orchymont

Observed names: Dorchymont, Faustine, Faustine D'Orchymont, Faustine d'Orchymont, d'Orchymont, Faustine
ORCID: 0000-0002-3726-1648
Observed ORCID: 0000-0002-3726-1648
OpenAlex ID: A5072407848
Supramolecular Rotaxane‐Based Multi‐Modal Probes for Cancer Biomarker Imaging**
2022 · Faustine d'Orchymont, Jason P. Holland · Angewandte Chemie International Edition · 36
PDF
A rotaxane-based platform for tailoring the pharmacokinetics of cancer-targeted radiotracers
2022 · Faustine d'Orchymont, Jason P. Holland · Chemical Science · 19
PDF
Charting the Chemical and Mechanistic Scope of Light-Triggered Protein Ligation
2022 · Daniel F. Earley, Amaury Guillou, et al. · JACS Au · 17
Synthesis, characterization and biological activity of organometallic derivatives of the antimalarial drug mefloquine as new antischistosomal drug candidates
2018 · Faustine d'Orchymont, Jeannine Hess, et al. · MedChemComm · 16
Asymmetric rotaxanes as dual-modality supramolecular imaging agents for targeting cancer biomarkers
2023 · Faustine d’Orchymont, Jason P. Holland · Communications Chemistry · 15
PDF
Cooperative Capture Synthesis of Functionalized Heterorotaxanes─Chemical Scope, Kinetics, and Mechanistic Studies
2023 · Faustine d’Orchymont, Jason P. Holland · Journal of the American Chemical Society · 14
PDF
Impact of Surgical Lights on the Performance of Fluorescence-Guided Surgery Systems: A Pilot Study
2023 · Lavinia E. Chiti, Brian Park, et al. · Animals · 8
PDF
Performance of two clinical fluorescence imaging systems with different targeted and non-targeted near-infrared fluorophores: a cadaveric explorative study
2023 · Lavinia E. Chiti, Benjamin Husi, et al. · Frontiers in Veterinary Science · 8
PDF
Supramolecular Rotaxane‐Based Multi‐Modal Probes for Cancer Biomarker Imaging**
2022 · Faustine d'Orchymont, Jason P. Holland · Angewandte Chemie · 6
PDF
In vitro evaluation of PET radiotracers for imaging synaptic density, the acetylcholine transporter, AMPA-tarp-γ8 and muscarinic M4 receptors in Alzheimer’s disease
2024 · Faustine d’Orchymont · American Journal of Nuclear Medicine and Molecular Imaging · 3
PDF
Control of whole-body glucose metabolism by central lactate in the presence of antipsychotics
2026 · Sandra Pereira, Faustine d’Orchymont, et al. · Translational Psychiatry
PDF
Chelators for the Development of Complexes Radiolabeled With Ruthenium-97/103: a New Theranostic Tool for Nuclear Imaging and Endoradiotherapy
2026 · Barbara Lugato, Cyrille Alliot, et al. · EANM Innovation
Unlocking the Potential of Ruthenium Radioisotopes for Radiopharmaceutical Development
2026 · Maximilian Anderla, Barbara Lugato, et al. · EANM Innovation
Synthesis, Radiosynthesis, in Vitro and in Vivo Evaluation of the GABAA-Benzodiazepine Receptor Agonist [11C]RO6899880
2025 · Faustine d’Orchymont, Junchao Tong, et al. · ACS Medicinal Chemistry Letters
Comparison of [18F]FEOBV, [3H]VAT, [3H]MK-6884 and [3H]JNJ-64511070 for imaging Alzheimer’s disease
2023 · Faustine d’Orchymont, Andrea Narvaez, et al. · Nuclear Medicine and Biology
Supramolecular chemistry in the synthesis of radiopharmaceuticals
2022 · Faustine d’Orchymont, Jason Holland · Nuclear Medicine and Biology
Investigating the chemical scope of protein-ligation using photoactivatable chelates
2022 · Daniel Earley, Amaury Guillou, et al. · Nuclear Medicine and Biology
A multi-modality platform employing supramolecular chemistry to radiolabel antibodies
2021 · Faustine d’Orchymont, Jason Holland · Nuclear Medicine and Biology
Expanding the Chemistry Palette for Radiotracer Synthesis
2020 · Jennifer Lamb, Daniel F. Earley, et al. · CHIMIA International Journal for Chemistry
PDF
Works count: 23
Citation count: 142
H-index: 8
I10-index: 6
Year
Topic
Type